Leelyn Smith’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-215
Closed -$51.6K 238
2022
Q4
$51.6K Sell
215
-70
-25% -$15.7K 0.01% 178
2022
Q3
$52K Sell
285
-75
-21% -$14.9K 0.02% 151
2022
Q2
$61K Sell
360
-100
-22% -$21.5K 0.02% 185
2022
Q1
$115K Hold
460
0.03% 149
2021
Q4
$118K Hold
460
0.03% 150
2021
Q3
$112K Hold
460
0.03% 150
2021
Q2
$95K Hold
460
0.03% 166
2021
Q1
$87K Buy
460
+140
+44% +$24.7K 0.03% 182
2020
Q4
$53K Sell
320
-95
-23% -$13.9K 0.02% 192
2020
Q3
$52K Hold
415
0.02% 186
2020
Q2
$40K Buy
+415
New +$43.1K 0.02% 217

Other funds holding HCA

Leelyn Smith's HCA Position: Q1 2023 in Review

Leelyn Smith sold out of HCA Healthcare (HCA) in Q1 2023, closing a stake of 215 shares — an estimated $51.6K sold.

Leelyn Smith first reported a position in HCA in Q2 2020 and held it in 11 quarters. The position peaked at $118K in Q4 2021. 970 funds tracked by Wall St. Rank hold HCA as of Q1 2023.

  • Leelyn Smith reported no remaining HCA Healthcare position as of Q1 2023 after selling out during the quarter.
  • Leelyn Smith sold 215 HCA Healthcare shares in Q1 2023, an estimated $51.6K.
  • Leelyn Smith first reported a position in HCA Healthcare in Q2 2020 and held it in 11 quarters.
  • Leelyn Smith's HCA Healthcare position peaked at $118K in Q4 2021.
  • 970 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2023.

Based on Leelyn Smith's 13F filing for Q1 2023, filed 12 May 2023.